Circulating EBV-CTLp as a Biomarker of Clinical Response to Tabelecleucel
Christopher Haqq MD, PhD, discusses his research at ASCO 2019.
All articles by Stephen Cho
Exploring Indications With Venetoclax
Rod Humerickhouse, MD, PhD, discusses the latest research at ASCO 2019.
S-TRAC: Adjuvant Sunitinib Phase 3 Trial in High-risk RCC
Daniel James George, MD
Advanced Soft Tissue Sarcomas: Dox + Olaratumab vs. Dox + PBO
Alexander Spira MD, PhD, discusses his research at the ASCO 2019 meeting.
CLL14 Phase 3 Trial: Venetoclax Combo as First-line Therapy
Michael Hallek, MD, discusses data at the ASCO 2019 meeting in Chicago, IL.
Managing the Failed Rotator Cuff Repair
The Problem Rotator cuff repair results in predictable pain relief and a variable return of function in the majority of patients. However, it may take up to a year to achieve maximum improvement in shoulder strength and function. In certain cases patients may continue to experience pain and weakness in the shoulder following rotator cuff…
Single-agent Ibrutinib Therapy Provides Durable Response in CLL/SLL
Treatment with single-agent ibrutinib was well-tolerated and provided durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Pembrolizumab Demonstrates Anti-tumor Activity, Acceptable Safety Profile in Urothelial Cancer
For the treatment of patients with advanced urothelial cancer, pembrolizumab demonstrated anti-tumor activity and an acceptable safety profile.
Diagnostic Laparoscopy: A Way To Reduce Likelihood of Futile Laparotomy?
Treatment with diagnostic laparoscopy rather than primary surgery may lower the rate of futile laparotomies among women with suspected advanced ovarian cancer.
Asian Men With Metastatic PCa Have Superior ADT Outcomes
Those of Asian ethnicity have superior median overall and PCa-specific survival to men of any other race.
Next post in Prostate Cancer
